These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 317987)

  • 1. [Inhibitory action of Hodgkin's disease patients serum on T lymphocytes E rosette forming ability (author's transl)].
    Panteghini M; Piccioli E; Migliorati T; Ruggeri G
    Ann Sclavo; 1979; 21(4):483-93. PubMed ID: 317987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between serum factors and T lymphocytes in Hodgkin's disease. Use as a diagnostic test.
    Fuks Z; Strober S; Kaplan HS
    N Engl J Med; 1976 Dec; 295(23):1273-8. PubMed ID: 185517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. E-rosette inhibiting substance in Hodgkin's disease spleen extracts.
    Bieber MM; Fuks Z; Kaplan HS
    Clin Exp Immunol; 1977 Sep; 29(3):369-75. PubMed ID: 201408
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversal of cell surface abnormalities of T lymphocytes in hodgkin's disease after in vitro incubation in fetal sera.
    Fuks Z; Strober S; King DP; Kaplan HS
    J Immunol; 1976 Oct; 117(4):1331-5. PubMed ID: 1086325
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Cellular immunity in patients with Hodgkin's disease: modification induced by incubating lymphocytes with fetal calf serum and Hodgkin's serum].
    Rambotti P; Velardi A; Spinozzi F; Falini B; Martelli MF
    Boll Ist Sieroter Milan; 1979 Mar; 58(1):90-9. PubMed ID: 552840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro stimulation of T-cell rosette formation by antiserum to thymus factor in Hodgkin's disease.
    Zółtowska A; Arendt M; Gan J
    Arch Immunol Ther Exp (Warsz); 1984; 32(1):51-7. PubMed ID: 6332594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Pathol Biol (Paris); 1978; 26(3-4):159-62. PubMed ID: 355984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hodgkin's disease. T lymphocyte defect in patients in complete remission (author's transl)].
    Lang JM; Bigel P; Oberling F; Mayer S
    Sem Hop; 1978 Nov 8-15; 54(37-40):1155-8. PubMed ID: 217096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of levamisole on E-rosette-forming cells in vivo and in vitro in Hodgkin's disease.
    Ramot B; Biniaminov M; Shoham C; Rosenthal E
    N Engl J Med; 1976 Apr; 294(15):809-11. PubMed ID: 1082545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of levamisole, thymic humoral factor and indomethacin on e-rosette formation of lymphocytes in Hodgkin's disease.
    Ramot B; Rosenthal E; Biniaminov M; Ben-Bassat I
    Isr J Med Sci; 1981 Apr; 17(4):232-5. PubMed ID: 7195385
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal active rosette-forming-cells in untreated patients with Hodgkin's disease.
    Lang JM; Bigel P; Oberling F; Mayer S
    Biomedicine; 1977 Dec; 27(9-10):322-4. PubMed ID: 606306
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Autologous rosette-forming capacity of T-lymphocytes in Hodgkin's disease.
    Bodolay E; Berényi E; Sonkoly I; Szegedi G
    Acta Med Hung; 1984; 41(2-3):113-9. PubMed ID: 6611543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subpopulations of human T lymphocytes in patients with Hodgkin's disease before and after treatment.
    Karande AA; Gulwani B; Advani SH; Gangal SG
    Neoplasma; 1982; 29(2):149-59. PubMed ID: 6981068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hodgkin's disease in children: investigation of T and B lymphocytes.
    Ilyin NV; Kolygin BA; Letsky VB; Fedoreev GA; Zubzhitsky YN
    Neoplasma; 1978; 25(1):75-81. PubMed ID: 305545
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The rosette test with sensitized sheep erythrocytes, acid phosphatase and alpha-naphthylacetate esterase in an acid medium: comparative immunocytochemical T-cell exhibition in Hodgkin's disease].
    Plat M; Plat U; Fleischer J; Wolf H; Palitzsch M; Hofmann R; Reinhardt U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(1):87-95. PubMed ID: 2472333
    [No Abstract]   [Full Text] [Related]  

  • 16. Studies on the high- and low-affinity rosette-forming T-lymphocytes in patients with Hodgkin's and non-Hodgkin's lymphoma.
    Kadhim S; Rees RC; Potter CW; Walker R; Hancock BW
    Eur J Cancer (1965); 1981 May; 17(5):569-75. PubMed ID: 6975211
    [No Abstract]   [Full Text] [Related]  

  • 17. [T and B lymphocytes in chronic lymphocytic leukemia and Hodgkin's disease. Electron microscopic and immunologic studies].
    Cohnen G
    Veroff Pathol; 1975; (0):1-99. PubMed ID: 49138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunologic parameters in childhood Hodgkin's disease II. T and B lymphocytes in the peripheral blood of normal children and in the spleen and peripheral blood of children with Hodgkin's disease.
    de Sousa M; Tan CT; Siegal FP; Filippa DA; Tan R; Good RA
    Pediatr Res; 1978 Feb; 12(2):143-7. PubMed ID: 306089
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T and B lymphocytes in lymph nodes and spleen of patients with Hodgkin's disease.
    Berényi E; Sonkoly I; Pálóczi K; Balázs G; Szegedi G
    Neoplasma; 1979; 26(3):307-13. PubMed ID: 394011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Persisting deficiency of cell mediated immunity in Hodgkin's disease in complete remission (author's transl)].
    Lang JM; Bigel P; Giron C; Faradji A; Oberling F; Mayer S
    Nouv Presse Med; 1979 Nov; 8(44):3629-32. PubMed ID: 316521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.